|1.||Roberts, Jason A: 19 articles (01/2016 - 03/2008)|
|2.||Nicolau, David P: 18 articles (09/2015 - 04/2002)|
|3.||Lipman, Jeffrey: 17 articles (01/2016 - 07/2007)|
|4.||Kuti, Joseph L: 15 articles (09/2015 - 04/2002)|
|5.||Woods, Gail L: 11 articles (06/2004 - 01/2002)|
|6.||Roberts, Michael S: 10 articles (08/2015 - 07/2007)|
|7.||Teppler, Hedy: 10 articles (08/2005 - 01/2002)|
|8.||Paterson, David L: 9 articles (04/2015 - 12/2007)|
|9.||Giacometti, Andrea: 8 articles (12/2011 - 01/2002)|
|10.||Ghiselli, Roberto: 8 articles (12/2011 - 01/2002)|
11/01/1982 - "Evidence from prospective studies indicates that piperacillin is a highly effective agent for the treatment of patients with infections caused by susceptible organisms."
04/01/2011 - "The infection was treated successfully with piperacillin. "
09/01/1991 - "The altered pharmacokinetics of piperacillin during pregnancy suggest that higher doses may be required for effective treatment of serious infections in pregnant women near term."
12/01/1989 - "It is concluded that single agent piperacillin is as effective as the combination therapy used in this study for the treatment of hospitalized gynecological infections."
04/01/1983 - "Piperacillin (PIPC) was employed for prophylactic treatment in 18 patients against postoperative infections and for therapeutic treatment in 3 patients against complicated infections of urogenital tracts. "
10/01/2001 - "At first, piperacillin sodium (PIPC) was started, but a spiking fever persisted. "
04/01/1993 - "A 43-year-old woman was treated with piperacillin (PIPC) for spiking fever. "
01/01/1988 - "Although emergence of resistance was not seen, one isolate had an increase in minimum inhibitory concentration from 8 to 128 micrograms/ml. There were no serious adverse reactions to piperacillin; only one patient developed fever possibly related to piperacillin. "
11/01/1986 - "The pooled data indicated that the piperacillin treatment group did not differ from the combined cephalosporin treatment groups with respect to prophylactic response, presence of febrile morbidity, fever index, duration of postoperative hospitalization and incidence of reported adverse experiences."
03/01/1985 - "The fever resolved shortly after the piperacillin treatment was stopped, as did the widespread rashes in the two patients who developed them. "
08/01/2015 - "The objectives of this study were to describe piperacillin exposure in febrile neutropenia patients and determine whether therapeutic drug monitoring (TDM) can be used to increase the achievement of pharmacokinetic (PK)/pharmacodynamic (PD) targets. "
07/01/2013 - "This study was conducted to determine the efficacy, and cost effectiveness of Piperacillin-Tazobactem as monotherapy in febrile neutropenia. "
01/01/2007 - "Report of neutropenia associated with piperacillin usage prior to 15 days of therapy is a novel finding that requires further evaluation. "
01/01/2007 - "This review sought to assess the occurrence of piperacillin-induced neutropenia, describe characteristics of affected patients and assess the reporting modalities that most accurately classify this ADR. "
01/01/2007 - "Systematic review of piperacillin-induced neutropenia."
10/01/1993 - "Diverse purulent inflammatory complications were treated with Pipril in doses of 8 to 24 g a day in 27 patients with malignant tumors. "
10/01/1993 - "[Piperacillin in the treatment of suppurative inflammatory complications in cancer patients]."
06/01/1989 - "We examined the use of optimal sampling theory in the determination of the pharmacokinetics of piperacillin in febrile, neutropenic cancer patients. "
06/01/1989 - "A prospective evaluation of optimal sampling theory in the determination of the steady-state pharmacokinetics of piperacillin in febrile neutropenic cancer patients."
06/01/1987 - "Piperacillin in prophylaxis and therapy of gynecologic cancer patients."
|5.||Urinary Tract Infections (Urinary Tract Infection)
01/01/1986 - "[Clinical studies of efficacy of piperacillin against complicated urinary tract infections]."
09/01/1988 - "[Reevaluation of clinical efficacy of piperacillin against complicated urinary tract infections]."
01/01/1986 - "All but 1 child responded favorably to piperacillin therapy, and 1 child with a urinary tract infection relapsed 10 days after discontinuation of the therapy. "
01/01/1986 - "Clinical efficacy of piperacillin against 74 cases with complicated urinary tract infection was examined. "
06/01/1987 - "Piperacillin therapy for complicated urinary tract infections caused by enterococci alone and in association with multi-drug resistant pathogens."
|7.||Anti-Bacterial Agents (Antibiotics)
|1.||Drug Therapy (Chemotherapy)
|4.||Renal Replacement Therapy (Therapies, Renal Replacement)